APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Aminoglycosides Antibiotics

Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.

Selected research

Industry Growth & Trends

Global Aminoglycosides Antibiotics Industry Growth and Trends Forecast to 2032

Report ID 173962830128 December 2025100 pages

Choose your research edition.

Industry ResearchAminoglycosides Antibiotics Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Aminoglycosides Antibiotics Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Aminoglycosides Antibiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Aminoglycosides Antibiotics Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Aminoglycosides Antibiotics Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.

The classification of Aminoglycosides Antibiotics includes Neomycin, Tobramycin, Gentamicin, Amikacin, Etimicin and Others. In addition, the proportion of Neomycin in 2019 is about 26%, and Etimicin mainly sales in China.

Aminoglycosides Antibiotics is widely used for Hospital, Clinic, Post Care Facility, Government & Military and Others. The most proportion of Aminoglycosides Antibiotics is for clinic, and the proportion in 2019 is about 35%.

Read the full market overview

Europe is the largest consumption place, with a consumption market share nearly 26% in 2019. Following Europe, China is the second largest consumption place with the consumption market share of about 16%.

Jemicare, Teva, Novartis Pharmaceuticals, Fangyuan-pharma, Aike Pharmaceutical, Cipla, etc. are the leaders of the industry.

Report Scope

This report provides a structured, data-driven view of the global Aminoglycosides Antibiotics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Aminoglycosides Antibiotics market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Aminoglycosides Antibiotics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Aminoglycosides Antibiotics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Aminoglycosides Antibiotics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Aminoglycosides Antibiotics Market by Company

Jemicare

Teva

Novartis

Fangyuan-pharma

Aike Pharmaceutical

Cipla

Pfizer

Fresenius Kabi

Sun Pharma

Hikma

Lannett Company

Aminoglycosides Antibiotics Segment by Type

Neomycin

Tobramycin

Gentamicin

Amikacin

Etimicin

Others

Aminoglycosides Antibiotics Segment by Application

Hospital

Clinic

Post Care Facility

Government & Military

Others

Aminoglycosides Antibiotics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aminoglycosides Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Aminoglycosides Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aminoglycosides Antibiotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Aminoglycosides Antibiotics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Aminoglycosides Antibiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Neomycin Table 2. Major Company of Tobramycin Table 3. Major Company of Gentamicin Table 4. Major Company of Amikacin Table 5. Major Company of Etimicin Table 6. Major Company of Others Table 7. Global Aminoglycosides Antibiotics Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Aminoglycosides Antibiotics Sales by Type (2021-2026) & (M Units) Table 9. Global Aminoglycosides Antibiotics Sales Market Share in Volume by Type (2021-2026) Table 10. Global Aminoglycosides Antibiotics Sales by Type (2021-2026) & (US$ Million) Table 11. Global Aminoglycosides Antibiotics Sales Market Share in Value by Type (2021-2026) Table 12. Global Aminoglycosides Antibiotics Price by Type (2021-2026) & (USD/Unit) Table 13. Global Aminoglycosides Antibiotics Sales by Type (2027-2032) & (M Units) Table 14. Global Aminoglycosides Antibiotics Sales Market Share in Volume by Type (2027-2032) Table 15. Global Aminoglycosides Antibiotics Sales by Type (2027-2032) & (US$ Million) Table 16. Global Aminoglycosides Antibiotics Sales Market Share in Value by Type (2027-2032) Table 17. Global Aminoglycosides Antibiotics Price by Type (2027-2032) & (USD/Unit) Table 18. North America Aminoglycosides Antibiotics Sales by Type (2021-2026) & (M Units) Table 19. North America Aminoglycosides Antibiotics Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Aminoglycosides Antibiotics Sales by Type (2021-2026) & (M Units) Table 21. Europe Aminoglycosides Antibiotics Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Aminoglycosides Antibiotics Sales by Type (2021-2026) & (M Units) Table 23. Asia-Pacific Aminoglycosides Antibiotics Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Aminoglycosides Antibiotics Sales by Type (2021-2026) & (M Units) Table 25. Latin America Aminoglycosides Antibiotics Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Aminoglycosides Antibiotics Sales by Type (2021-2026) & (M Units) Table 27. Middle East and Africa Aminoglycosides Antibiotics Sales by Type (2021-2026) & (US$ Million) Table 28. Aminoglycosides Antibiotics Industry Trends Table 29. Aminoglycosides Antibiotics Industry Drivers Table 30. Aminoglycosides Antibiotics Industry Opportunities and Challenges Table 31. Aminoglycosides Antibiotics Industry Restraints Table 32. Global Aminoglycosides Antibiotics Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Aminoglycosides Antibiotics Revenue Market Share by Company (2021-2026) Table 34. Global Aminoglycosides Antibiotics Sales by Company (2021-2026) & (M Units) Table 35. Global Aminoglycosides Antibiotics Sales Share by Company (2021-2026) Table 36. Global Aminoglycosides Antibiotics Market Price by Company (2021-2026) & (USD/Unit) Table 37. Global Aminoglycosides Antibiotics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Aminoglycosides Antibiotics Major Company Production Sites and Headquarters Table 39. Global Aminoglycosides Antibiotics Company, Product Type & Application Table 40. Global Aminoglycosides Antibiotics Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Aminoglycosides Antibiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Aminoglycosides Antibiotics Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Aminoglycosides Antibiotics Sales by Region (2021-2026) & (M Units) Table 45. Global Aminoglycosides Antibiotics Sales Market Share in Volume by Region (2021-2026) Table 46. Global Aminoglycosides Antibiotics Sales by Region (2021-2026) & (US$ Million) Table 47. Global Aminoglycosides Antibiotics Sales Market Share in Value by Region (2021-2026) Table 48. Global Aminoglycosides Antibiotics Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 49. Global Aminoglycosides Antibiotics Sales by Region (2027-2032) & (M Units) Table 50. Global Aminoglycosides Antibiotics Sales Market Share in Volume by Region (2027-2032) Table 51. Global Aminoglycosides Antibiotics Sales by Region (2027-2032) & (US$ Million) Table 52. Global Aminoglycosides Antibiotics Sales Market Share in Value by Region (2027-2032) Table 53. Global Aminoglycosides Antibiotics Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 54. Global Aminoglycosides Antibiotics Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Aminoglycosides Antibiotics Sales by Application (2021-2026) & (M Units) Table 56. Global Aminoglycosides Antibiotics Sales Market Share in Volume by Application (2021-2026) Table 57. Global Aminoglycosides Antibiotics Sales by Application (2021-2026) & (US$ Million) Table 58. Global Aminoglycosides Antibiotics Sales Market Share in Value by Application (2021-2026) Table 59. Global Aminoglycosides Antibiotics Price by Application (2021-2026) & (USD/Unit) Table 60. Global Aminoglycosides Antibiotics Sales by Application (2027-2032) & (M Units) Table 61. Global Aminoglycosides Antibiotics Sales Market Share in Volume by Application (2027-2032) Table 62. Global Aminoglycosides Antibiotics Sales by Application (2027-2032) & (US$ Million) Table 63. Global Aminoglycosides Antibiotics Sales Market Share in Value by Application (2027-2032) Table 64. Global Aminoglycosides Antibiotics Price by Application (2027-2032) & (USD/Unit) Table 65. North America Aminoglycosides Antibiotics Sales by Application (2021-2026) & (M Units) Table 66. North America Aminoglycosides Antibiotics Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Aminoglycosides Antibiotics Sales by Application (2021-2026) & (M Units) Table 68. Europe Aminoglycosides Antibiotics Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Aminoglycosides Antibiotics Sales by Application (2021-2026) & (M Units) Table 70. Asia-Pacific Aminoglycosides Antibiotics Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Aminoglycosides Antibiotics Sales by Application (2021-2026) & (M Units) Table 72. Latin America Aminoglycosides Antibiotics Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Aminoglycosides Antibiotics Sales by Application (2021-2026) & (M Units) Table 74. Middle East and Africa Aminoglycosides Antibiotics Sales by Application (2021-2026) & (US$ Million) Table 75. Jemicare Company Information Table 76. Jemicare Business Overview Table 77. Jemicare Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 78. Jemicare Aminoglycosides Antibiotics Product Portfolio Table 79. Jemicare Recent Development Table 80. Teva Company Information Table 81. Teva Business Overview Table 82. Teva Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 83. Teva Aminoglycosides Antibiotics Product Portfolio Table 84. Teva Recent Development Table 85. Novartis Company Information Table 86. Novartis Business Overview Table 87. Novartis Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 88. Novartis Aminoglycosides Antibiotics Product Portfolio Table 89. Novartis Recent Development Table 90. Fangyuan-pharma Company Information Table 91. Fangyuan-pharma Business Overview Table 92. Fangyuan-pharma Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. Fangyuan-pharma Aminoglycosides Antibiotics Product Portfolio Table 94. Fangyuan-pharma Recent Development Table 95. Aike Pharmaceutical Company Information Table 96. Aike Pharmaceutical Business Overview Table 97. Aike Pharmaceutical Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. Aike Pharmaceutical Aminoglycosides Antibiotics Product Portfolio Table 99. Aike Pharmaceutical Recent Development Table 100. Cipla Company Information Table 101. Cipla Business Overview Table 102. Cipla Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. Cipla Aminoglycosides Antibiotics Product Portfolio Table 104. Cipla Recent Development Table 105. Pfizer Company Information Table 106. Pfizer Business Overview Table 107. Pfizer Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 108. Pfizer Aminoglycosides Antibiotics Product Portfolio Table 109. Pfizer Recent Development Table 110. Fresenius Kabi Company Information Table 111. Fresenius Kabi Business Overview Table 112. Fresenius Kabi Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 113. Fresenius Kabi Aminoglycosides Antibiotics Product Portfolio Table 114. Fresenius Kabi Recent Development Table 115. Sun Pharma Company Information Table 116. Sun Pharma Business Overview Table 117. Sun Pharma Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 118. Sun Pharma Aminoglycosides Antibiotics Product Portfolio Table 119. Sun Pharma Recent Development Table 120. Hikma Company Information Table 121. Hikma Business Overview Table 122. Hikma Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 123. Hikma Aminoglycosides Antibiotics Product Portfolio Table 124. Hikma Recent Development Table 125. Lannett Company Company Information Table 126. Lannett Company Business Overview Table 127. Lannett Company Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 128. Lannett Company Aminoglycosides Antibiotics Product Portfolio Table 129. Lannett Company Recent Development Table 130. North America Aminoglycosides Antibiotics Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 131. North America Aminoglycosides Antibiotics Sales by Country (2021-2026) & (M Units) Table 132. North America Aminoglycosides Antibiotics Sales Market Share by Country (2021-2026) Table 133. North America Aminoglycosides Antibiotics Sales Forecast by Country (2027-2032) & (M Units) Table 134. North America Aminoglycosides Antibiotics Sales Market Share Forecast by Country (2027-2032) Table 135. North America Aminoglycosides Antibiotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 136. North America Aminoglycosides Antibiotics Market Size by Country (2021-2026) & (US$ Million) Table 137. North America Aminoglycosides Antibiotics Market Share by Country (2021-2026) Table 138. North America Aminoglycosides Antibiotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 139. North America Aminoglycosides Antibiotics Market Share Forecast by Country (2027-2032) Table 140. Europe Aminoglycosides Antibiotics Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 141. Europe Aminoglycosides Antibiotics Sales by Country (2021-2026) & (M Units) Table 142. Europe Aminoglycosides Antibiotics Sales Market Share by Country (2021-2026) Table 143. Europe Aminoglycosides Antibiotics Sales Forecast by Country (2027-2032) & (M Units) Table 144. Europe Aminoglycosides Antibiotics Sales Market Share Forecast by Country (2027-2032) Table 145. Europe Aminoglycosides Antibiotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 146. Europe Aminoglycosides Antibiotics Market Size by Country (2021-2026) & (US$ Million) Table 147. Europe Aminoglycosides Antibiotics Market Share by Country (2021-2026) Table 148. Europe Aminoglycosides Antibiotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 149. Europe Aminoglycosides Antibiotics Market Share Forecast by Country (2027-2032) Table 150. Asia-Pacific Aminoglycosides Antibiotics Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 151. Asia-Pacific Aminoglycosides Antibiotics Sales by Country (2021-2026) & (M Units) Table 152. Asia-Pacific Aminoglycosides Antibiotics Sales Market Share by Country (2021-2026) Table 153. Asia-Pacific Aminoglycosides Antibiotics Sales Forecast by Country (2027-2032) & (M Units) Table 154. Asia-Pacific Aminoglycosides Antibiotics Sales Market Share Forecast by Country (2027-2032) Table 155. Asia-Pacific Aminoglycosides Antibiotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 156. Asia-Pacific Aminoglycosides Antibiotics Market Size by Country (2021-2026) & (US$ Million) Table 157. Asia-Pacific Aminoglycosides Antibiotics Market Share by Country (2021-2026) Table 158. Asia-Pacific Aminoglycosides Antibiotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 159. Asia-Pacific Aminoglycosides Antibiotics Market Share Forecast by Country (2027-2032) Table 160. Latin America Aminoglycosides Antibiotics Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 161. Latin America Aminoglycosides Antibiotics Sales by Country (2021-2026) & (M Units) Table 162. Latin America Aminoglycosides Antibiotics Sales Market Share by Country (2021-2026) Table 163. Latin America Aminoglycosides Antibiotics Sales Forecast by Country (2027-2032) & (M Units) Table 164. Latin America Aminoglycosides Antibiotics Sales Market Share Forecast by Country (2027-2032) Table 165. Latin America Aminoglycosides Antibiotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 166. Latin America Aminoglycosides Antibiotics Market Size by Country (2021-2026) & (US$ Million) Table 167. Latin America Aminoglycosides Antibiotics Market Share by Country (2021-2026) Table 168. Latin America Aminoglycosides Antibiotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 169. Latin America Aminoglycosides Antibiotics Market Share Forecast by Country (2027-2032) Table 170. Middle East and Africa Aminoglycosides Antibiotics Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 171. Middle East and Africa Aminoglycosides Antibiotics Sales by Country (2021-2026) & (M Units) Table 172. Middle East and Africa Aminoglycosides Antibiotics Sales Market Share by Country (2021-2026) Table 173. Middle East and Africa Aminoglycosides Antibiotics Sales Forecast by Country (2027-2032) & (M Units) Table 174. Middle East and Africa Aminoglycosides Antibiotics Sales Market Share Forecast by Country (2027-2032) Table 175. Middle East and Africa Aminoglycosides Antibiotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 176. Middle East and Africa Aminoglycosides Antibiotics Market Size by Country (2021-2026) & (US$ Million) Table 177. Middle East and Africa Aminoglycosides Antibiotics Market Share by Country (2021-2026) Table 178. Middle East and Africa Aminoglycosides Antibiotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 179. Middle East and Africa Aminoglycosides Antibiotics Market Share Forecast by Country (2027-2032) Table 180. Key Raw Materials Table 181. Raw Materials Key Suppliers Table 182. Aminoglycosides Antibiotics Distributors List Table 183. Aminoglycosides Antibiotics Customers List Table 184. Research Programs/Design for This Report Table 185. Authors List of This Report Table 186. Secondary Sources Table 187. Primary Sources List of Figures Figure 1. Aminoglycosides Antibiotics Image Figure 2. Global Aminoglycosides Antibiotics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Aminoglycosides Antibiotics Market Size (2021-2032) & (US$ Million) Figure 4. Global Aminoglycosides Antibiotics Sales (2021-2032) & (M Units) Figure 5. Neomycin Image Figure 6. Global Neomycin Sales YoY Growth (2021-2032) & (M Units) Figure 7. Tobramycin Image Figure 8. Global Tobramycin Sales YoY Growth (2021-2032) & (M Units) Figure 9. Gentamicin Image Figure 10. Global Gentamicin Sales YoY Growth (2021-2032) & (M Units) Figure 11. Amikacin Image Figure 12. Global Amikacin Sales YoY Growth (2021-2032) & (M Units) Figure 13. Etimicin Image Figure 14. Global Etimicin Sales YoY Growth (2021-2032) & (M Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (M Units) Figure 17. Global Aminoglycosides Antibiotics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Aminoglycosides Antibiotics Market Share by Type 2025 VS 2032 Figure 19. North America Aminoglycosides Antibiotics Sales Market Share in Volume by Type in 2025 Figure 20. North America Aminoglycosides Antibiotics Sales Market Share in Value by Type in 2025 Figure 21. Europe Aminoglycosides Antibiotics Sales Market Share in Volume by Type in 2025 Figure 22. Europe Aminoglycosides Antibiotics Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Aminoglycosides Antibiotics Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Aminoglycosides Antibiotics Sales Market Share in Value by Type in 2025 Figure 25. Latin America Aminoglycosides Antibiotics Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Aminoglycosides Antibiotics Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Aminoglycosides Antibiotics Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Aminoglycosides Antibiotics Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Aminoglycosides Antibiotics Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Hospital Image Figure 32. Global Hospital Sales YoY Growth (2021-2032) & (M Units) Figure 33. Clinic Image Figure 34. Global Clinic Sales YoY Growth (2021-2032) & (M Units) Figure 35. Post Care Facility Image Figure 36. Global Post Care Facility Sales YoY Growth (2021-2032) & (M Units) Figure 37. Government & Military Image Figure 38. Global Government & Military Sales YoY Growth (2021-2032) & (M Units) Figure 39. Others Image Figure 40. Global Others Sales YoY Growth (2021-2032) & (M Units) Figure 41. Global Aminoglycosides Antibiotics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Aminoglycosides Antibiotics Market Share by Application 2025 VS 2032 Figure 43. North America Aminoglycosides Antibiotics Sales Market Share in Volume by Application in 2025 Figure 44. North America Aminoglycosides Antibiotics Sales Market Share in Value by Application in 2025 Figure 45. Europe Aminoglycosides Antibiotics Sales Market Share in Volume by Application in 2025 Figure 46. Europe Aminoglycosides Antibiotics Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific Aminoglycosides Antibiotics Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific Aminoglycosides Antibiotics Sales Market Share in Value by Application in 2025 Figure 49. Latin America Aminoglycosides Antibiotics Sales Market Share in Volume by Application in 2025 Figure 50. Latin America Aminoglycosides Antibiotics Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa Aminoglycosides Antibiotics Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa Aminoglycosides Antibiotics Sales Market Share in Value by Application in 2025 Figure 53. North America Aminoglycosides Antibiotics Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 54. North America Aminoglycosides Antibiotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America Aminoglycosides Antibiotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America Aminoglycosides Antibiotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Aminoglycosides Antibiotics Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 58. Europe Aminoglycosides Antibiotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Aminoglycosides Antibiotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Aminoglycosides Antibiotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Aminoglycosides Antibiotics Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 62. Asia-Pacific Aminoglycosides Antibiotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Aminoglycosides Antibiotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific Aminoglycosides Antibiotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Aminoglycosides Antibiotics Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 66. Latin America Aminoglycosides Antibiotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Aminoglycosides Antibiotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America Aminoglycosides Antibiotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Aminoglycosides Antibiotics Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 70. Middle East and Africa Aminoglycosides Antibiotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Aminoglycosides Antibiotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa Aminoglycosides Antibiotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Aminoglycosides Antibiotics Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. Aminoglycosides Antibiotics Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Neomycin
  • Tobramycin
  • Gentamicin
  • Amikacin
  • Etimicin
  • Others
Applications
  • Hospital
  • Clinic
  • Post Care Facility
  • Government & Military
  • Others
Companies covered
  • Jemicare
  • Teva
  • Novartis
  • Fangyuan-pharma
  • Aike Pharmaceutical
  • Cipla
  • Pfizer
  • Fresenius Kabi
  • Sun Pharma
  • Hikma
  • Lannett Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Aminoglycosides Antibiotics Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Aminoglycosides Antibiotics Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Aminoglycosides Antibiotics Market by Type
  6. 1.3.1 Neomycin
  7. 1.3.2 Tobramycin
  8. 1.3.3 Gentamicin
  9. 1.3.4 Amikacin
  10. 1.3.5 Etimicin
  11. 1.3.6 Others
  12. 1.4 Global Aminoglycosides Antibiotics Market Size by Type
  13. 1.4.1 Global Aminoglycosides Antibiotics Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Aminoglycosides Antibiotics Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Aminoglycosides Antibiotics Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Aminoglycosides Antibiotics Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Aminoglycosides Antibiotics Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Aminoglycosides Antibiotics Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Aminoglycosides Antibiotics Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Aminoglycosides Antibiotics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Aminoglycosides Antibiotics Industry Trends
  2. 2.2 Aminoglycosides Antibiotics Industry Drivers
  3. 2.3 Aminoglycosides Antibiotics Industry Opportunities and Challenges
  4. 2.4 Aminoglycosides Antibiotics Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Aminoglycosides Antibiotics Revenue (2021-2026)
  2. 3.2 Global Top Players by Aminoglycosides Antibiotics Sales (2021-2026)
  3. 3.3 Global Top Players by Aminoglycosides Antibiotics Price (2021-2026)
  4. 3.4 Global Aminoglycosides Antibiotics Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Aminoglycosides Antibiotics Major Company Production Sites & Headquarters
  6. 3.6 Global Aminoglycosides Antibiotics Company, Product Type & Application
  7. 3.7 Global Aminoglycosides Antibiotics Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Aminoglycosides Antibiotics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Aminoglycosides Antibiotics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Aminoglycosides Antibiotics Tier 1, Tier 2, and Tier 3
4 Aminoglycosides Antibiotics Regional Status and Outlook
  1. 4.1 Global Aminoglycosides Antibiotics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Aminoglycosides Antibiotics Historic Market Size by Region
  3. 4.2.1 Global Aminoglycosides Antibiotics Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Aminoglycosides Antibiotics Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Aminoglycosides Antibiotics Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Aminoglycosides Antibiotics Forecasted Market Size by Region
  7. 4.3.1 Global Aminoglycosides Antibiotics Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Aminoglycosides Antibiotics Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Aminoglycosides Antibiotics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Aminoglycosides Antibiotics by Application
  1. 5.1 Aminoglycosides Antibiotics Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Post Care Facility
  5. 5.1.4 Government & Military
  6. 5.1.5 Others
  7. 5.2 Global Aminoglycosides Antibiotics Market Size by Application
  8. 5.2.1 Global Aminoglycosides Antibiotics Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Aminoglycosides Antibiotics Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Aminoglycosides Antibiotics Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Aminoglycosides Antibiotics Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Aminoglycosides Antibiotics Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Aminoglycosides Antibiotics Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Aminoglycosides Antibiotics Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Aminoglycosides Antibiotics Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Jemicare
  2. 6.1.1 Jemicare Company Information
  3. 6.1.2 Jemicare Business Overview
  4. 6.1.3 Jemicare Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Jemicare Aminoglycosides Antibiotics Product Portfolio
  6. 6.1.5 Jemicare Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva Aminoglycosides Antibiotics Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Aminoglycosides Antibiotics Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Fangyuan-pharma
  20. 6.4.1 Fangyuan-pharma Company Information
  21. 6.4.2 Fangyuan-pharma Business Overview
  22. 6.4.3 Fangyuan-pharma Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Fangyuan-pharma Aminoglycosides Antibiotics Product Portfolio
  24. 6.4.5 Fangyuan-pharma Recent Developments
  25. 6.5 Aike Pharmaceutical
  26. 6.5.1 Aike Pharmaceutical Company Information
  27. 6.5.2 Aike Pharmaceutical Business Overview
  28. 6.5.3 Aike Pharmaceutical Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Aike Pharmaceutical Aminoglycosides Antibiotics Product Portfolio
  30. 6.5.5 Aike Pharmaceutical Recent Developments
  31. 6.6 Cipla
  32. 6.6.1 Cipla Company Information
  33. 6.6.2 Cipla Business Overview
  34. 6.6.3 Cipla Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Cipla Aminoglycosides Antibiotics Product Portfolio
  36. 6.6.5 Cipla Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Aminoglycosides Antibiotics Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 Fresenius Kabi
  44. 6.8.1 Fresenius Kabi Company Information
  45. 6.8.2 Fresenius Kabi Business Overview
  46. 6.8.3 Fresenius Kabi Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Fresenius Kabi Aminoglycosides Antibiotics Product Portfolio
  48. 6.8.5 Fresenius Kabi Recent Developments
  49. 6.9 Sun Pharma
  50. 6.9.1 Sun Pharma Company Information
  51. 6.9.2 Sun Pharma Business Overview
  52. 6.9.3 Sun Pharma Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sun Pharma Aminoglycosides Antibiotics Product Portfolio
  54. 6.9.5 Sun Pharma Recent Developments
  55. 6.10 Hikma
  56. 6.10.1 Hikma Company Information
  57. 6.10.2 Hikma Business Overview
  58. 6.10.3 Hikma Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Hikma Aminoglycosides Antibiotics Product Portfolio
  60. 6.10.5 Hikma Recent Developments
  61. 6.11 Lannett Company
  62. 6.11.1 Lannett Company Company Information
  63. 6.11.2 Lannett Company Business Overview
  64. 6.11.3 Lannett Company Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Lannett Company Aminoglycosides Antibiotics Product Portfolio
  66. 6.11.5 Lannett Company Recent Developments
7 North America by Country
  1. 7.1 North America Aminoglycosides Antibiotics Sales by Country
  2. 7.1.1 North America Aminoglycosides Antibiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Aminoglycosides Antibiotics Sales by Country (2021-2026)
  4. 7.1.3 North America Aminoglycosides Antibiotics Sales Forecast by Country (2027-2032)
  5. 7.2 North America Aminoglycosides Antibiotics Market Size by Country
  6. 7.2.1 North America Aminoglycosides Antibiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Aminoglycosides Antibiotics Market Size by Country (2021-2026)
  8. 7.2.3 North America Aminoglycosides Antibiotics Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Aminoglycosides Antibiotics Sales by Country
  2. 8.1.1 Europe Aminoglycosides Antibiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Aminoglycosides Antibiotics Sales by Country (2021-2026)
  4. 8.1.3 Europe Aminoglycosides Antibiotics Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Aminoglycosides Antibiotics Market Size by Country
  6. 8.2.1 Europe Aminoglycosides Antibiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Aminoglycosides Antibiotics Market Size by Country (2021-2026)
  8. 8.2.3 Europe Aminoglycosides Antibiotics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Aminoglycosides Antibiotics Sales by Country
  2. 9.1.1 Asia-Pacific Aminoglycosides Antibiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Aminoglycosides Antibiotics Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Aminoglycosides Antibiotics Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Aminoglycosides Antibiotics Market Size by Country
  6. 9.2.1 Asia-Pacific Aminoglycosides Antibiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Aminoglycosides Antibiotics Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Aminoglycosides Antibiotics Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Aminoglycosides Antibiotics Sales by Country
  2. 10.1.1 South America Aminoglycosides Antibiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Aminoglycosides Antibiotics Sales by Country (2021-2026)
  4. 10.1.3 South America Aminoglycosides Antibiotics Sales Forecast by Country (2027-2032)
  5. 10.2 South America Aminoglycosides Antibiotics Market Size by Country
  6. 10.2.1 South America Aminoglycosides Antibiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Aminoglycosides Antibiotics Market Size by Country (2021-2026)
  8. 10.2.3 South America Aminoglycosides Antibiotics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Aminoglycosides Antibiotics Sales by Country
  2. 11.1.1 Middle East and Africa Aminoglycosides Antibiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Aminoglycosides Antibiotics Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Aminoglycosides Antibiotics Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Aminoglycosides Antibiotics Market Size by Country
  6. 11.2.1 Middle East and Africa Aminoglycosides Antibiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Aminoglycosides Antibiotics Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Aminoglycosides Antibiotics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Aminoglycosides Antibiotics Value Chain Analysis
  2. 12.1.1 Aminoglycosides Antibiotics Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Aminoglycosides Antibiotics Production Mode & Process
  7. 12.2 Aminoglycosides Antibiotics Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Aminoglycosides Antibiotics Distributors
  10. 12.2.3 Aminoglycosides Antibiotics Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst